News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,065 Results
Type
Article (41777)
Company Profile (262)
Press Release (671026)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (208021)
Career Advice (2039)
Deals (35885)
Drug Delivery (98)
Drug Development (82566)
Employer Resources (173)
FDA (16377)
Job Trends (15094)
News (351492)
Policy (33124)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2657)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (50512)
ALS (90)
Alzheimer's disease (1398)
Antibody-drug conjugate (ADC) (115)
Approvals (16379)
Artificial intelligence (263)
Autoimmune disease (21)
Automation (15)
Bankruptcy (365)
Best Places to Work (11811)
BIOSECURE Act (18)
Biosimilars (107)
Biotechnology (185)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (267)
Cancer (2115)
Cardiovascular disease (171)
Career advice (1705)
Career pathing (29)
CAR-T (145)
Cell therapy (411)
Cervical cancer (19)
Clinical research (66829)
Collaboration (821)
Compensation (524)
Complete response letters (19)
COVID-19 (2633)
CRISPR (39)
C-suite (231)
Cystic fibrosis (104)
Data (2076)
Decentralized trials (2)
Denatured (19)
Depression (40)
Diabetes (257)
Diagnostics (6444)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (125)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (87775)
Editorial (36)
Employer branding (21)
Employer resources (147)
Events (114803)
Executive appointments (721)
FDA (17582)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (742)
Gene editing (104)
Generative AI (24)
Gene therapy (297)
GLP-1 (706)
Government (4490)
Grass and pollen (5)
Guidances (51)
Healthcare (19268)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (26)
Infectious disease (2776)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (94)
Interviews (316)
IPO (16641)
IRA (41)
Job creations (3705)
Job search strategy (1451)
Kidney cancer (9)
Labor market (36)
Layoffs (468)
Leadership (16)
Legal (8052)
Liver cancer (73)
Lung cancer (305)
Lymphoma (140)
Machine learning (5)
Management (58)
Manufacturing (289)
MASH (63)
Medical device (13477)
Medtech (13482)
Mergers & acquisitions (19762)
Metabolic disorders (662)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (87)
Neuropsychiatric disorders (24)
Neuroscience (1917)
NextGen: Class of 2025 (6661)
Non-profit (4595)
Northern California (2558)
Now hiring (38)
Obesity (354)
Opinion (206)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (149)
Partnered (21)
Patents (225)
Patient recruitment (100)
Peanut (48)
People (58293)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20853)
Phase II (29367)
Phase III (21901)
Pipeline (1124)
Policy (131)
Postmarket research (2650)
Preclinical (9091)
Press Release (68)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (250)
Rare diseases (384)
Real estate (6051)
Recruiting (65)
Regulatory (22590)
Reports (46)
Research institute (2436)
Resumes & cover letters (354)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (67)
Series A (129)
Series B (83)
Service/supplier (14)
Sickle cell disease (56)
Southern California (2205)
Special edition (14)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3650)
State (2)
Stomach cancer (13)
Supply chain (66)
Tariffs (24)
The Weekly (29)
United States (22510)
Vaccines (677)
Venture capitalists (38)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Last 7 days (476)
Last 30 days (2213)
Last 365 days (33467)
2025 (9469)
2024 (35789)
2023 (40532)
2022 (51742)
2021 (56314)
2020 (54805)
2019 (47489)
2018 (35754)
2017 (32676)
2016 (32260)
2015 (38357)
2014 (32048)
2013 (27138)
2012 (29438)
2011 (30048)
2010 (28279)
Location
Africa (747)
Alabama (52)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38585)
Australia (6309)
California (5848)
Canada (1947)
China (497)
Colorado (259)
Connecticut (274)
Delaware (135)
Europe (84194)
Florida (878)
Georgia (203)
Idaho (57)
Illinois (527)
India (25)
Indiana (306)
Iowa (9)
Japan (151)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (867)
Massachusetts (4429)
Michigan (215)
Minnesota (382)
Mississippi (2)
Missouri (80)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (68)
New Jersey (1719)
New Mexico (29)
New York (1683)
North Carolina (1046)
North Dakota (8)
Northern California (2558)
Ohio (196)
Oklahoma (14)
Oregon (34)
Pennsylvania (1321)
Puerto Rico (11)
Rhode Island (30)
South America (1126)
South Carolina (20)
South Dakota (1)
Southern California (2205)
Tennessee (101)
Texas (871)
Utah (173)
Virginia (139)
Washington D.C. (61)
Washington State (539)
West Virginia (3)
Wisconsin (59)
713,065 Results for "model n inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fangzhou Inc. integrates DeepSeek open-source AI Model to enhance Internet healthcare
February 18, 2025
·
3 min read
Deals
Model N to be Acquired by Vista Equity Partners For $1.25 Billion
Model N announced that it has entered into a definitive agreement to be acquired by Vista Equity Partners, a leading global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses.
April 8, 2024
·
10 min read
Press Releases
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
March 25, 2025
·
5 min read
Press Releases
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
April 16, 2025
·
7 min read
FDA
FDA To Replace Some Animal Testing With AI, Human ‘Organoid’ Lab Models
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin “immediately,” no specific timetable was given.
April 11, 2025
·
2 min read
·
Tristan Manalac
Business
Model N Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results
Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after market close on Thursday, November 9, 2023.
October 19, 2023
·
1 min read
Drug Development
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model
NanoViricides, Inc. reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model.
June 20, 2024
·
10 min read
Business
Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue
Model N, the leader in revenue optimization and compliance announced new product innovations geared towards the increasingly complex regulatory environment for global pharma manufacturers.
November 7, 2023
·
4 min read
Press Releases
Synchron Unveils Chiral™, the World’s First Cognitive AI Brain Foundation Model
March 19, 2025
·
5 min read
Press Releases
TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
March 6, 2025
·
3 min read
1 of 71,307
Next
